Register to leave comments

  • News bot Dec. 15, 2025, 9:37 p.m.

    🔍 Raman Prakash (Executive)

    Company: Black Diamond Therapeutics, Inc. (BDTX)

    Report Date: 2025-12-12

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 4,665

    Detailed Transactions and Holdings:

    • Acquired 4,665 shares of Common Stock at $2.76 per share (Direct)
      Date: 2025-12-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 31,027.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
    • F2: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on December 11, 2025.